Replimune Group Inc

REPLNASDAQ · USD
13.07USD+0.20 (+1.56%)
1210

Replimune Group Inc (REPL) Options Open Interest

REPL options open interest is 91,822 contracts. The 2-week average daily volume is 4,341 contracts across the chain.

Read more

Monitoring REPL open interest helps you see where real money is positioned on Replimune Group Inc's options and which strikes are attracting the most commitment from traders. Replimune Group Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor REPL options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising REPL options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Replimune Group Inc to settle.

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells.

Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where REPL open interest is concentrated. Our scanner maps Replimune Group Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Replimune Group Inc's options open interest as the signal it is, not as an afterthought.

2026-09-25
Calls
15.000.500.50161%+0.296157
18.000.400.40227%+0.196951
13.001.151.15162%+0.531237
14.000.700.70152%+0.394028
14.500.300.30112%+0.258122
Puts
13.000.051.200.6375%-0.511841
14.000.151.901.038%-1.000025
15.000.054.702.38121%-0.783023
10.004.504.50958%-0.190420
12.500.900.90148%-0.402411

As of September 17, 2026

Follow the money

Track REPL open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial